Latest Technology And Operations News

StepChange Holdings expects FY26 revenue to exceed $55 million with normalised EBITDA of $5 million, driven by organic growth and the BroadReach acquisition. The company also strengthens its leadership by appointing Giuseppe Todesco as COO.

NobleOak Life Limited boosted its Embedded Value by 9% to $2.34 per share as of December 2025, driven by strong premium growth and market share gains. The insurer exceeded its FY26 in-force premium guidance with a 16% increase to $538 million.

Challenger Limited is merging its Fidante funds management business with Channel Capital, creating Channel Group with $150 billion in assets. Challenger will hold a 45% stake and expects a $100 million pre-tax gain in FY27.

Evion Group’s Panthera Graphite Technologies joint venture posted a US$530,000 EBITDA in its first full year of commercial production, operating at just 20-25% capacity and setting the stage for substantial earnings growth.

1414 Degrees has initiated the scale-up of its SiNTL silicon anode production, moving beyond lab-scale to manufacturer-relevant volumes. This step unlocks formal third-party evaluations and OEM engagement, with full-stack battery development targeting drones, UAVs, and satellites underway.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.

Encounter Resources inks a non-binding MoU with Echion Technologies and Switch Technologies to develop a lithium-niobium battery industry leveraging its high-grade Aileron niobium resource.

Vista Group International has inked a six-year contract to transition Cinépolis Mexico, the world’s largest cinema circuit by attendance, to its Vista Cloud Operational Excellence platform starting in 2026.

Humm Group reported a 5.1% rise in average assets under management to $5.4 billion in 3Q26, despite lower loan originations and ongoing corporate irregular costs. Credit quality remains stable as the company navigates macroeconomic headwinds and strategic product transitions.

Acusensus Limited maintains its FY26 revenue and EBITDA guidance while advancing multiple enforcement programs across the US, UK, New Zealand, and Australia, underpinned by new product developments and international growth.

Sigma Healthcare reports robust growth in Chemist Warehouse sales across Australia and internationally, announces a joint venture to enter the UK market, and secures a major distribution centre lease in New Zealand to support its expanding network.

IDT Australia is poised for its strongest FY26 finish since its transformation began, forecasting a dramatic narrowing of EBITDA losses and revenue growth driven by strategic partnerships and operational upgrades.